Search

everythinglearnresearchcommunity

for

Search:↓

Systematic symptom assessment helps prioritize care for children undergoing cancer treatment.

Alpha-blockers are recommended first for recent CP/CPPS, while antimicrobials are not advised for long-term cases.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Combining low-dose dutasteride with finasteride improved a man's hair loss.

Proper management of skin and hair side effects from chemotherapy improves patients' quality of life.

A thorough diagnostic process and teamwork are crucial for managing complex hyperandrogenism in postmenopausal women.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Adipose-derived stem cells and platelet-rich plasma together can protect skin and hair from radiotherapy damage.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Topical Minoxidil effectively and safely regrows hair in cancer patients.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Taking finasteride for over a month before surgery reduces blood loss during TURP.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

Onabotulinum toxin A may help treat trichotillomania and promote hair growth.

Tailored treatment is crucial for elderly men with BPH due to potential risks and benefits of medications.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Finasteride may not affect gynecomastia recurrence after mastectomy.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

Combining different treatments may be needed to effectively manage chronic prostatitis.

Retinol palmitate may reduce cancer relapses in early-stage lung cancer patients.

Methotrexate with corticosteroids can help regrow hair in severe alopecia areata but may cause relapses and side effects.

Dermatologists should carefully manage hair loss in cancer patients to improve their quality of life.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Including androgens in hormone therapy may lower breast cancer risk.

Combining medications is more effective for treating benign prostatic syndrome symptoms.